SCHEMBL5503240

SCHEMBL5503240

Cc1ccc2c(N3CCN(C(O)(C=O)c4ccc(F)cc4)CC3)nc(-c3ccccc3O)nc2c1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
SMAD3 P84022 1/20 0.45
MAPT P10636 5/20 0.43
TSHR P16473 2/20 0.43
ALDH1A1 P00352 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
GBA1 P04062 2/20 0.41
CHEK2 O96017 3/20 0.40
AURKA O14965 1/20 0.39
CYP1A2 P05177 3/20 0.38
CYP3A4 P08684 3/20 0.38
CYP2D6 P10635 2/20 0.38
HSD17B10 Q99714 1/20 0.38
CTNNB1 P35222 1/20 0.38
TCF7L2 Q9NQB0 1/20 0.38
MAPK1 P28482 1/20 0.38
RAD52 P43351 1/20 0.37
HRH4 Q9H3N8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5500371 0.94 KMT2A (0.53) MEN1KMT2ASMAD3MAPTTSHR
SCHEMBL5504311 0.94 KMT2A (0.53) MEN1KMT2ASMAD3MAPTTSHR
SCHEMBL5500395 0.88 CHEK2 (0.43) MEN1KMT2AMAPTGBA1CHEK2
SCHEMBL1084754 0.83 MAPT (0.60) MEN1KMT2ASMAD3MAPTTSHR
SCHEMBL5504061 0.80 ALDH1A1 (0.52) MEN1KMT2ASMAD3MAPTTSHR
SCHEMBL1623455 0.79 MEN1 (0.48) MEN1KMT2ASMAD3MAPTTSHR
SCHEMBL13769477 0.78 MEN1 (0.76) MEN1KMT2ASMAD3MAPTTSHR
SCHEMBL2734047 0.78 SMAD3 (0.73) MEN1KMT2ASMAD3MAPTTSHR
SCHEMBL1084407 0.78 CHEK2 (0.48) MEN1KMT2ASMAD3MAPTTSHR
SCHEMBL1622993 0.77 MEN1 (0.53) MEN1KMT2ASMAD3MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1784393-A1 QUINAZOLINES USEFUL AS MODULATORS OF ION CHANNELS Vertex Pharmaceuticals Incorporated (US) 2007-05-16 EP disclosed
WO-2006028904-A9 QUINAZOLINES USEFUL AS MODULATORS OF ION CHANNELS VERTEX PHARMA (US) 2006-06-22 WO disclosed
WO-2006028904-A1 QUINAZOLINES USEFUL AS MODULATORS OF ION CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2006-03-16 WO disclosed